These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32961008)

  • 1. Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View.
    Felicetti T; Manfroni G; Cecchetti V; Cannalire R
    ChemMedChem; 2020 Dec; 15(24):2391-2419. PubMed ID: 32961008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.
    Boldescu V; Behnam MAM; Vasilakis N; Klein CD
    Nat Rev Drug Discov; 2017 Aug; 16(8):565-586. PubMed ID: 28473729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-Spectrum Anti-Flavivirus Activity and Chemistry of Compounds Containing Sulfur and Oxygen Chalcogens.
    Sole Burali M; Cecchetti V; Manfroni G
    Curr Med Chem; 2023; 30(21):2396-2420. PubMed ID: 35702779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mosquito-Borne Flaviviruses and Current Therapeutic Advances.
    Qian X; Qi Z
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the identification of inhibitors of West Nile virus and other flaviviruses.
    Shi PY
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1567-73. PubMed ID: 12476954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
    Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
    ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in flavivirus antiviral drug discovery and vaccine development.
    Ray D; Shi PY
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flaviviruses are sensitive to inhibition of thymidine synthesis pathways.
    Fischer MA; Smith JL; Shum D; Stein DA; Parkins C; Bhinder B; Radu C; Hirsch AJ; Djaballah H; Nelson JA; Früh K
    J Virol; 2013 Sep; 87(17):9411-9. PubMed ID: 23824813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad-Spectrum Small-Molecule Inhibitors Targeting the SAM-Binding Site of Flavivirus NS5 Methyltransferase.
    Samrat SK; Bashir Q; Huang Y; Trieshmann CW; Tharappel AM; Zhang R; Chen K; Zheng YG; Li Z; Li H
    ACS Infect Dis; 2023 Jul; 9(7):1319-1333. PubMed ID: 37348028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approaches to flavivirus drug discovery.
    Botting C; Kuhn RJ
    Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
    Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
    Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in flavivirus drug discovery.
    Kok WM
    Expert Opin Drug Discov; 2016; 11(5):433-45. PubMed ID: 26966889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and functionality in flavivirus NS-proteins: perspectives for drug design.
    Bollati M; Alvarez K; Assenberg R; Baronti C; Canard B; Cook S; Coutard B; Decroly E; de Lamballerie X; Gould EA; Grard G; Grimes JM; Hilgenfeld R; Jansson AM; Malet H; Mancini EJ; Mastrangelo E; Mattevi A; Milani M; Moureau G; Neyts J; Owens RJ; Ren J; Selisko B; Speroni S; Steuber H; Stuart DI; Unge T; Bolognesi M
    Antiviral Res; 2010 Aug; 87(2):125-48. PubMed ID: 19945487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase.
    Brecher M; Chen H; Liu B; Banavali NK; Jones SA; Zhang J; Li Z; Kramer LD; Li H
    PLoS One; 2015; 10(6):e0130062. PubMed ID: 26098995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development.
    Geiss BJ; Stahla-Beek HJ; Hannah AM; Gari HH; Henderson BR; Saeedi BJ; Keenan SM
    J Biomol Screen; 2011 Sep; 16(8):852-61. PubMed ID: 21788392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis.
    Chong HY; Leow CY; Abdul Majeed AB; Leow CH
    Virus Res; 2019 Dec; 274():197770. PubMed ID: 31626874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies Towards Protease Inhibitors for Emerging Flaviviruses.
    Nitsche C
    Adv Exp Med Biol; 2018; 1062():175-186. PubMed ID: 29845533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
    Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
    Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.